LDLR and cardiovascular disorder: Consistent with the essential role of the LDLR in regulation of plasma LDL-cholesterol levels, therapies aimed at increasing LDLR levels, such as statins or antibodies against proprotein convertase subtilisin/kexin type 9, have proven to be the most effective treatments to reduce the incidence of cardiovascular disease [3].